Lower urinary tract destruction due to ketamine a report of 4 cases and review of literature

Journal of Addiction Medicine

Volumn 6, Issue 1, 2012, Pages 85-88

  Wu, Song ^a,b,c   Lai, Yongqin ^b   He, Yingying ^c   Li, Xianxin ^b,c   Guan, Zhichen ^b   Cai, Zhiming ^a,b,c  

^a SHENZHEN UNIVERSITY   (China)

^b Biomedical Research Institute   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Follow up; Hyaluronic acid; Ketamine; Lower urinary tract destruction

Indexed keywords

ALANINE AMINOTRANSFERASE; HYALURONIC ACID; KETAMINE;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTOURETHROGRAPHY; DRUG ABUSE; DYSURIA; FEMALE; HEMATURIA; HUMAN; LIVER FUNCTION TEST; LOWER URINARY TRACT SYMPTOM; MALE; OVERACTIVE BLADDER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URODYNAMICS;

ADULT; ANESTHETICS, DISSOCIATIVE; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KETAMINE; MALE; SUBSTANCE-RELATED DISORDERS; URINARY BLADDER; URODYNAMICS; UROGRAPHY; UROLOGIC DISEASES; YOUNG ADULT;

EID: 84863642895     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3182312863     Document Type: Review

References (11)

1. Chu PS, Kwok SC, Lam KM, et al. Street ketamine-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 2007;13(4):311-313.
2. Chu PS, Ma WK, Wong SC, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 2008;102(11):1616-1622.
3. Houwert RM, Roovers JP, Venema PL, et al. When to perform urodynamics before mid-urethral sling surgery for female stress urinary incontinence? Int Urogynecol J Pelvic Floor Dysfunct 2010;21(3):303-309.
4. Juszczak K, Ziomber A, Wyczolkowski M, et al. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats. J Physiol Pharmacol 2009;60(4):85-91.
5. Leppilahti M, Hellström P, Tammela TL, et al. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillationsonbladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 2002;60(1):46-51.
6. Lu L, Fang Y, Wang X, et al. Drug abuse in China: past, present and future. Cell Mol Neurobiol 2008;28(4):479-490.
7. Mak SK, Chan MTY, Bower WF, et al. Lower urinary tract changes in young adults using ketamine. J Urology 2011;186:610-614.
8. Mason K, Cottrell AM, Corrigan AG, et al. Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin Radiol 2010;65(10):795-800.
9. Muetzelfeldt L, Kamboj SK, Rees H, et al. Journal through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend 2008;95:219-229.
10. Soler R, Bruschini H, Truzzi JC, et al. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of nonbacterial cystitis. Int Braz J Urol 2008;34(4):503-511.
11. Valentini FA, Marti BG, Robain G, et al. Analysis of rhythmic rectal contractions during filling cystometry in women. Int Braz J Urol 2009;35(4):475-483.